About This ReportThis new 280-page report from VPGMarketResearch.com presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales projections for Hospitals, Commercial, Physician Offices, and Public Health Labs.    In addition to market share and sales forecasts, the report:-  Examines market applications of Molecular Diagnostics,     Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;-  Reviews features and operating characteristics of major analyzers used    for STD testing; -  Profiles key suppliers and potential market entrants developing innovative   technologies and products; and -  Analyzes emerging opportunities, alternative market penetration strategies,    market entry barriers/risks, and strategic planning issues.MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer productand financial literature, as well as... Research Beam Model: Research Beam Product ID: 350608 0 USD New
2016 Future Horizons and Growth Strategies in the US Sexually-Transmitted Diseases (STD) Diagnostic Testing Market: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Opportunities
 
 

2016 Future Horizons and Growth Strategies in the US Sexually-Transmitted Diseases (STD) Diagnostic Testing Market: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • Category : Diagnostic and Biotech
  • Published On : November   2015
  • Pages : 280
  • Publisher : VPGMarketResearch.com
 
 
 

About This Report

This new 280-page report from VPGMarketResearch.com presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales projections for Hospitals, Commercial, Physician Offices, and Public Health Labs.    

In addition to market share and sales forecasts, the report:

-  Examines market applications of Molecular Diagnostics,  
   Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

-  Reviews features and operating characteristics of major analyzers used
   for STD testing;

-  Profiles key suppliers and potential market entrants developing innovative
   technologies and products; and

-  Analyzes emerging opportunities, alternative market penetration strategies,
   market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product
and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.
 
Contains 280 pages and 18  tables

../toc/TOCTOTUSASexuallyTransmittedDiseasesMarketOutlookandOpportunities.pdf
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT